google-site-verification: googlec7193c3de77668c9.html
Wednesday , September 16 2026

Study identifies promising therapy to prevent relapses in rare neurological disease

[
An international study led by Mayo Clinic researchers has identified interleukin-6 (IL-6) receptor blockers as a promising option for preventing relapses in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). MOGAD is a rare autoimmune neurological disorder that can cause vision loss, paralysis and other serious neurological complications.


Source link

Advertisements

See also  Targeted nerve blocks sharply reduce pain, opioid use for children with severe leg fractures, study finds

Check Also

Guernsey charity gives alcohol consumption scorecard to residents

The charity said the 2023 Wellbeing Survey found that 35.2% of adults aged 16 and …

Autistic children ages 4–6 showed improved social skills after summer program

[ An Institute for Autism program for younger children with autism that is modeled on …

Burnham thanks well-wishers following his father’s death

Prime Minister Andy Burnham has thanked party leaders for their support following the death of …

Leave a Reply

Available for Amazon Prime